Day One Biopharmaceuticals, Inc.
Biotechnology · Healthcare
Board Member
2024-01-01–present
William Grossman
Board Member
Day One Biopharmaceuticals, Inc.
Equibles does not estimate personal net worth.
About William Grossman
William Grossman is recorded as Board Member at Day One Biopharmaceuticals, Inc. since January 17, 2024. Day One Biopharmaceuticals, Inc. reported in an 8-K filed April 23, 2026 that William Grossman resigned as director, effective April 23, 2026. Day One Biopharmaceuticals, Inc. reported in an 8-K filed January 17, 2024 that William Grossman was appointed Class II director, effective January 17, 2024. Day One Biopharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector.
“As of the Effective Time, Jeremy Bender, Habib Dable, Scott Garland, William Grossman, Natalie Holles, John Josey, Garry Nicholson and Saira Ramasastry each ceased to be directors of the Company and members of any committee of the Company's board of directors.”
“On January 16, 2024, upon the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors (the "Board") of Day One Biopharmaceuticals, Inc. (the "Company"), the Board increased the size of the Board to ten directors and appointed each of Habib J. Dable and William Grossman as a Class III and Class II director, respectively, effective as of January 17, 2024 (the "Effective Date").”
Affiliation history
-
Day One Biopharmaceuticals, Inc.
Board Member
SEC 8-K
Current2024-01-17–present
-
Day One Biopharmaceuticals, Inc.
Board Member
Proxy statement
2024-01-01–2026-04-23